Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAR-T
Research
As CAR-T gains ground on solid tumors, red tape blocks progress
A new highly sensitive CAR-T cell therapy was able to wipe out three different solid tumors in mice, an area where the approach has long struggled.
Darren Incorvaia
Feb 26, 2026 3:08pm
Gilead inks $8B Arcellx buyout to steer CAR-T into J&J showdown
Feb 23, 2026 7:30am
Allogeneic CAR-T biotechs fight to escape 'nuclear winter'
Feb 11, 2026 11:00am
AstraZeneca pens $630M pact for remaining China rights to CAR-T
Jan 19, 2026 10:35am
Link emerges to connect CAR-T therapy across solid, liquid tumors
Dec 15, 2025 1:18pm
'Unprecedented' data prime Kyverna for 1st autoimmune CAR-T drug
Dec 15, 2025 10:55am
